Skip to main content

Table 3 Patients’ characteristics

From: MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner

Subgroup

No. of subjects

miR16 levelsa

All

p value

CAF

p value

NF

p value

Sex

 Male

19

925 [441–2120]

0.746

925 [487–1961]

0.570

1180 [312–2109]

0.855

 Female

7

1330 [966–1641]

 

1314 [1012–2427]

 

1347 [700–1494]

 

Age

 < 70

15

1227 [384–1979]

0.567

1307 [649–2069]

0.750

1120 [252–1774]

0.470

 > 70

11

1105 [528–2120]

 

919 [531–2095]

 

1519 [606–1987]

 

Histology

 Adenocarcinoma

19

1112 [475–1519]

0.488

1105 [733–1466]

0.960

1120 [290–1519]

0.147

 Others

7

2078 [493–2475]

 

1307 [487–2966]

 

2216 [916–2442]

 

Stage

 I–II

9

1105 [528–1520]

0.566

800 [486–1224]

0.520

1433 [762–1537]

0.950

 III–IV

17

1227 [384–2295]

 

1307 [733–2456]

 

1120 [281–2120]

 

Grade

 G2

4

1217 [916–1479]]

0.946

1390 [1261–2230]

0.628

734 [277–1219]

0.490

 G3

16

922 [452–1658]

 

922 [553–2003]

 

1094 [286–1572]

 

Smoking

 Current

12

860 [310–1437]

0.215

1074 [722–2584]

0.980

324 [223–972]

0.006

 Formerb/Never

14

1470 [733–2120]

 

1126 [517–1590]

 

1589 [1494–2237]

 

COPD (GOLD)

 0

15

1553 [826–2467]

0.048

1307 [616–2711]

0.456

2078 [1494–2412]

0.004

 1–2

10

800 [324–1233]

 

860 [508–1331]

 

349 [281–1120]

 
  1. aData are median [IQR] of gTotalGeneSignal (Agilent Array)
  2. bFormer smoker > 12 months